Bookmark and Share
N,N-naphthaloylhydroxylamine (CID 25164) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(8)
 
 
Inactive(2)
 
 
Top Targets:
PLAT LOX(2)
 
 
Peptidase M17(2)
 
 
M1 APN 1(1)
 
 
PTZ00371(1)
 
 
BioAssay Types:
Confirmatory(6)
 
 
 
Literature(3)
 
 
Screening(1)
 
 
BioActivity Types:
IC50(8)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 10    Data Row: 10   Total Pages: 1   
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID131485169]
Average HUM17LAP IC50 8.38Name: Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Human M17LAP (HUM17LAP) [AID602407, Type: confirmatory]leucine aminopeptidase [Homo sapiens] [gi:4335941]
View
2
[SID103402267]
IC50 14In vitro inhibitory activity against RBL-1 5-LO [AID6809, Type: Literature]
View
3
[SID103402267]
IC50 14In vitro inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells(RBL-1) [AID7184, Type: Literature]Arachidonate 5-lipoxygenase [gi:729945]
View
4
[SID103402267]
IC50 14.1254Logarithmic value of inhibitory concentration against 5-lipoxygenase in rat basophilic leukemia cells (RBL-1) [AID7185, Type: Literature]Arachidonate 5-lipoxygenase [gi:729945]
View
5
[SID131485169]
Average PFM17LAP IC50 46.34QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) (3) [AID602309, Type: confirmatory]M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510]
View
6
[SID131485169]
Avg CC50 50Vero Cytoxicity Assay: A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) (3) [AID602317, Type: confirmatory]
View
7
[SID131485169]
Average PFM18AAP IC50 100Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP) (3) [AID602316, Type: confirmatory]M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220]
View
8
[SID131485169]
Late stage assay provider results from the probe development effort to identify inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (M17LAP): radiolabel-based cell-based assay to identify compounds that inhibit P. falciparum growth in RBCs Set 2 [AID743274, Type: screening]
View
9
[SID131485169]
IC50 15.7Late stage assay provider results from the probe development effort to identify inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (M17LAP): radiolabel-based cell-based dose response assay to identify compounds that inhibit P. falciparum growth in RBCs Set 2 [AID743273, Type: confirmatory]
View
10
[SID131485169]
Average PFM1AAP IC50 Counterscreen for inhibitors of PFM17LAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) (3) [AID602315, Type: confirmatory]m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:23615263]
View